At a glance

ClinicalIndex Comparison Record

N/ACompleted· 49 enrolled

Drug / intervention

Topical moisturizerother

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04045314

NCT04045314N/ACompleted

Compare CT.gov

Effect of an Emollient Cream Containing 0.5% Cannabidiol and 1% Hemp Oil in the Hydration and Erythema of the Skin

Avicanna Inc·interventional·Posted Aug 5, 2019·Updated Apr 28, 2020

In Brief

A clinical study evaluating Topical moisturizer for Cosmetics; Eczema. Completed, enrolled 49 participants across 1 site.

Detailed Summary

This research seeks to evaluate the short (i.e., after single application) and long-term (i.e., after periodic application) hydrating effect of a topical preparation containing CBD and hemp oil on the skin of the volar forearm as well as the effect on instrumentally measured erythema.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsCosmetics; Eczema

CountriesColombia

Collaborators--

Timeline

N/ACompletedFinished

2020202120222023202420252026

First PostedAug 2019

Enrollment StartAug 2019

Primary CompletionNov 2019

TodayJul 2026

First PostedAug 5, 2019

Enrollment StartAug 15, 2019

Primary CompletionNov 12, 2019

TodayJul 2, 2026

Enrollment to primary: 3 monthsPosted 6.9 years ago

Interventions

Topical moisturizerother

The investigational product is an intensive emollient cream that is applied topically on the skin and is manufactured by Avicanna Inc. This preparation contains widely used ingredients from mineral and botanical origin aimed at soothing and conditioning the skin as well as improving hydration. The moisturizer also contains 1% hemp oil rich in essential fatty acids and antioxidants as well as 0.5% of CBD with regulatory and conditioning effect on the skin